HomeOpen Access NewsDrug Development

Drug Development

iDOMO: New AI tool predicts synergistic drug combinations

Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex diseases like cancer.

Beating lung cancer with the AI edge

Prashant Warier, CEO and Founder, Qure.ai, explains beating lung cancer with the AI edge.

UK Cannabis Industry – the next Scottish Whisky

Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?

Thailand gives out one million free cannabis plants to promote legalisation

One million homes will be given cannabis plants across Thailand, to mark the legalisation and attract foreign tourists – to be used for ‘medicinal purposes’ only.

NIH begins clinical trial for Epstein-Barr virus vaccine

The clinical trial will test an Epstein-Barr virus vaccine developed by Novavax, one of just two attempts in over a decade.

Study explores cheaper way to produce compounds for pharmaceuticals

Researchers have developed a new tool that can make it easier and cheaper to fabricate the compounds needed for pharmaceuticals.

Ukrainian patients lose access to multiple sclerosis drug trial

Biotechnology giant Roche warns that multiple sclerosis (MS) drug trials are compromised in Ukraine - with patients losing access to crucial treatment.

Can people alleviate depression with psilocybin microdosing?

Psychedelic use has been found to have positive effects on mental disorders – now, psilocybin microdosing shows hope for relieving depression.

Powerful new COVID treatment cuts hospital deaths by 55%

So far, there is no treatment for severe cases - but now, clinical trials for a new COVID treatment show immense promise in preventing death.

Diabetes – Is life without insulin possible?

Imagine a life without insulin: Research is bringing us closer to a cure and could change the lives of diabetes patients

Scientists create non-hormonal male birth control 

Scientists made progress on the implementation of male birth control, which could someday split contraceptive responsibility between all genders.

Next-generation digital tools for mobility in research & health

Beatrix Vereijken and Lynn Rochester share how Mobilise-D develops digital technology to measure mobility in daily life to transform clinical research and health.

Finding innovative ways to deal with bacteria

Professor of Evolutionary Biology Ashleigh S. Griffin discusses harnessing the power of evolutionary process instead of fighting it, particularly regarding bacterial cells and cooperation.

Drug with the ability to reprogramme aggressive brain tumours 

Study shows L-methylfolate, when administered alongside standard therapy for glioblastomas, changed the DNA process within a patients tumour

Combining AI tech with drug development efforts

Can Artificial Intelligence (AI) change the process of drug development for the pharmaceutical industry?

BioNTech will ship mobile mRNA vaccine factories to Africa

BioNTech reveal plans to ship mobile mRNA vaccine factories to some countries in Africa - with vaccine manufacturing expected only in late 2023.

Treating multi-drug resistant tuberculosis

Andrew Nunn, Professor of Epidemiology, Medical Research Council Clinical Trials Unit at UCL, describes the first phase 3 trial of a shortened treatment for MDR-TB.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders